MRD / Regn No. : THBC\23-24\01978 Date : 21/07/2026
Patient Name : Satish Badhe Age & Gender : 64 Yrs. / Male
Contact No. : 9870602449 UHID :
Ht / Wt / BMI : BP S / BP D :
Allergies : NONE Referred By :
   
Problem List : T2DM (01/Jan/2013) | HTN (01/Jan/2006) |
Subjective : T2DM-10YRS,HTN-17YRS,RETINA 6 MTHLY - NORMAL,HBA1C-6.9%,ADDING DAPAGLIFLOZIN AND REDUCING METFORMIN
Objective : 29-JUN-2026 REPORTS,HB-14.8/ HBA1C-7.2%,FBS-125,ALT-20/ AST-20,CR-0.89,TC-137/ TG-1-03/ LDL-73/ HDL-43,TSH-0.859,VITD-22.18
Plan : FBS / PPBS > 15 DAYS OF ADDING DAPAVEL 10 MG AND REDUCING GALVUS MET FROM 1000 TO 500 MG BOTH TIMES,IF ANY URINARY ISSUES - TO LET ME KNOW  
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET ROSUVASTATIN 5MG
CREVAST 5 MG
ORAL 0-0-0-1 AD
4 MTHS
2 DRISE 60,000 UNITS ORAL 1/15 DAYS ANYTIME OF DAY
4 MTHS
3 NERVIHENZ ORAL 0-1-0 AL
2 MTHS
4 GALVUS MET 50/500 MG ORAL 1-0-1 ABF / AD
6 MTHS
5 DAPAVEL 10 MG ORAL 1-0-0 ABF
4 MTHS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 30/Nov/2025
Tests Suggested For Next Visit : HBA1C / FBS / PPBS / URINE FOR MICROALB:CREAT RATIO > 4 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: